Exane Derivatives’s Blackstone BX Stock Holding History

Exane Derivatives’s Portfolio BX Stock Details BX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-400	Closed	-$362	–	615
2017 Q3	$362	Hold	400	–	–	﹤0.01%	479
2017 Q2	$3.6K	Hold	400	–	–	﹤0.01%	438
2017 Q1	$13.2K	Hold	400	–	–	﹤0.01%	343
2016 Q4	$44.8K	Buy	400 +150	+60%	+$3.89K	0.01%	304
2016 Q3	$19.8K	Buy	+250	New	+$6.6K	﹤0.01%	364

Other funds holding BX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exane Derivatives's BX Position: Q2 2020 in Review

Exane Derivatives sold out of Blackstone (BX) in Q2 2020, closing a stake of 12 shares — an estimated $547 sold.

Exane Derivatives first reported a position in BX in Q1 2015 and held it in 19 quarters. The position peaked at $7.47M in Q1 2017. 1,022 funds tracked by Wall St. Rank hold BX as of Q2 2020.

Exane Derivatives reported no remaining Blackstone position as of Q2 2020 after selling out during the quarter.
Exane Derivatives sold 12 Blackstone shares in Q2 2020, an estimated $547.
Exane Derivatives first reported a position in Blackstone in Q1 2015 and held it in 19 quarters.
Exane Derivatives's Blackstone position peaked at $7.47M in Q1 2017.
1,022 funds tracked by Wall St. Rank held Blackstone as of Q2 2020.

Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.